Status:
COMPLETED
Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support
Lead Sponsor:
Bezmialem Vakif University
Conditions:
Progesterone
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The invesigators aimed to seperate the patients,which is going to be applied IUI, to two different groups as prospective randomized controlled ;assess the efficacy of the two different way pressurised...
Detailed Description
Approxymately %10-15 of the couples who are in reproductive age ,have infertility issues. %30-40 male factor ,%40-50 female factor and %20-25 both factors play a role in infertility etiology. Contribu...
Eligibility Criteria
Inclusion
- Absence of follicles larger than 10 mm on basal ultrasound
- Endometrial thickness less than 5 mm
- Patients with FSH\<10 IU/ml, E2\<60-80 pg/ml in the blood hormone test performed on the third day of the cycle and patients with antral follicle count above 7 on ultrasound
- Total motile sperm count greater than 10 million/ml
- 18-40 years old female, 18-50 years old male
- Anovulation, patients diagnosed with unexplained mild male factor infertility
- Female partners, who's BMI\<25 kg/m²
- Being voluntarily
Exclusion
- Other infertility reasons
- The patients who doesn't meet the criterias
- Refusing to attend to the research
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT05276531
Start Date
April 1 2022
End Date
September 1 2022
Last Update
September 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bezmialem Vakif University
Istanbul, Turkey (Türkiye)